MedPath
NMPA Approval

Doxofylline Injection

国药准字H20244081

June 18, 2024

Drug Information

多索茶碱注射液

注射剂

20ml:0.2g

化学药品

June 18, 2024

Company Information

Applicant Company

湖北省孝感市云梦县经济开发区和平路8号

Manufacturing Company

湖北省孝感市云梦县经济开发区和平路8号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

多索茶碱注射液 - NMPA 批准文号 | MedPath